Journal Article

Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD

Zhu, Lixin, Mastrandrea, Lucy, Tsompana, Maria, Nugent, Colleen A, Jiao, Na, Genco, Robert J, Chapa-Rodriguez, Adrian, Zhu, Ruixin, Baker, Susan S, Buck, Michael J, Liu, Wensheng, Baker, Robert D

2018

Overview

ObjectiveBile acids are regulators of lipid and glucose metabolism, and modulate inflammation in the liver and other tissues. Primary bile acids such as cholic acid and chenodeoxycholic acid (CDCA) are produced in the liver, and converted into secondary bile acids such as deoxycholic acid (DCA) and lithocholic acid by gut microbiota. Here we investigated the possible roles of bile acids in non-alcoholic fatty liver disease (NAFLD) pathogenesis and the impact of the gut microbiome on bile acid signalling in NAFLD.DesignSerum bile acid levels and fibroblast growth factor 19 (FGF19), liver gene expression profiles and gut microbiome compositions were determined in patients with NAFLD, high-fat diet-fed rats and their controls.ResultsSerum concentrations of primary and secondary bile acids were increased in patients with NAFLD. In per cent, the farnesoid X receptor (FXR) antagonistic DCA was increased, while the agonistic CDCA was decreased in NAFLD. Increased mRNA expression for cytochrome P450 7A1, Na+-taurocholate cotransporting polypeptide and paraoxonase 1, no change in mRNA expression for small heterodimer partner and bile salt export pump, and reduced serum FGF19 were evidence of impaired FXR and fibroblast growth factor receptor 4 (FGFR4)-mediated signalling in NAFLD. Taurine and glycine metabolising bacteria were increased in the gut of patients with NAFLD, reflecting increased secondary bile acid production. Similar changes in liver gene expression and the gut microbiome were observed in high-fat diet-fed rats.ConclusionsThe serum bile acid profile, the hepatic gene expression pattern and the gut microbiome composition consistently support an elevated bile acid production in NAFLD. The increased proportion of FXR antagonistic bile acid explains, at least in part, the suppression of hepatic FXR-mediated and FGFR4-mediated signalling. Our study suggests that future NAFLD intervention may target the components of FXR signalling, including the bile acid converting gut microbiome.

• Publisher: BMJ Publishing Group Ltd and British Society of Gastroenterology,BMJ Publishing Group LTD
• Subject: Acid production / Acids / Animals / Bile / bile acid / bile acid metabolism / Bile acids / Bile Acids and Salts - blood / Bile Acids and Salts - metabolism / Body mass index / Chenodeoxycholic acid / Cholesterol / Cholesterol 7-alpha-Hydroxylase - metabolism / Cholic acid / Cytochrome P450 / Deoxycholic acid / Diabetes / Diet, High-Fat / Fatty liver / Female / Fibroblast growth factor receptor 4 / Fibroblast Growth Factors - metabolism / Fibroblasts / Gastrointestinal Microbiome - physiology / Gene expression / Gene Expression Profiling / Glucose metabolism / Glycine / Growth factors / Hepatology / High fat diet / Homeostasis / Humans / Insulin resistance / Intervention / intestinal microbiology / Intestinal microflora / Lipid metabolism / Lipids / Liver diseases / Male / Metabolism / Microbiomes / Microbiota / Middle Aged / Non-alcoholic Fatty Liver Disease - diagnosis / Non-alcoholic Fatty Liver Disease - metabolism / Non-alcoholic Fatty Liver Disease - microbiology / nonalcoholic steatohepatitis / Paraoxonase / Paraoxonase 1 / Patients / Rats / Receptors, Cytoplasmic and Nuclear - metabolism / Rodents / Signal Transduction - physiology / Taurine